Large institutional investors are positioning for growth as a leading biopharmaceutical firm enters the obesity market and ...

AbbVie’s lost exclusivity for Humira is offset by immunology and neurology sales, diversified by its emerging oncology ...

Selecting winning stocks in early 2026 requires looking beyond short-term noise, as U.S. equities respond to easing inflation ...

The investment bank said many companies faced thesis-changing Phase 3 readouts this year, with outcomes that could materially reshape valuations regardless of the broader macro backdrop. But UBS also ...

Not sure if that brilliant article was penned by a human or AI? Here are some simple ways to tell. Rachel is a freelancer based in Echo Park, Los Angeles and has been writing and producing content for ...